Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines this year, the Covid-19 pandemic remains a threat to…
27/08/2021 - 7 minutes
Janssen
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
31/10/2019 - 2 minutes
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
22/08/2019 - 2 minutes
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could…
11/06/2019 - 2 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma
The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to…
25/01/2019 - 2 minutes
Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease
The Israeli biotech BiomX has teamed up with Janssen to use its microbiome technology in…
13/12/2018 - 2 minutes
Llama Antibodies Could Be the Key to Universal Flu Prevention
Researchers have developed a new approach to prevent the flu that can protect against all…
01/11/2018 - 3 minutes
A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect…
06/07/2018 - 2 minutes
Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug
Janssen Biotech and Theravance Biopharma will develop together a drug to treat bowel inflammation diseases…
08/02/2018 - 2 minutes
Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could…
04/12/2017 - 3 minutes
